Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Thomas K. Equels currently holds 267,426 shares of AIM ImmunoTech Inc. (AIM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas K. Equels has been a net buyer of AIM stock. They have purchased $460.7K and sold $0 worth of shares.
Thomas K. Equels's most recent insider trade was on Nov 24, 2021, when they sold 11,627 shares at $1.29 per share.
Thomas K. Equels serves as Executive at AIM ImmunoTech Inc. (AIM). They have executed 37 insider transactions totaling $460.7K over their tenure at the company.
Thomas K. Equels holds the position of Executive at AIM ImmunoTech Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Thomas K. Equels has shown a buying trading pattern, with $460.7K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Thomas K. Equels was on Jun 21, 2019, when they purchased $118.5K worth of HEB shares. This transaction involved 29,404 shares at $4.03 per share.
Thomas K. Equels currently owns 267,426 shares of AIM ImmunoTech Inc. (AIM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Thomas K. Equels's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Thomas K. Equels has 37 Form 4 filings on record as an insider at AIM ImmunoTech Inc..
Set alerts for Thomas K. Equels and 40,000+ other insiders.